The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 21, 2017

Filed:

May. 15, 2015
Applicants:

Biorest Ltd., Tel Aviv, IL;

Oregon Health & Science University, Portland, OR (US);

Inventors:

Yoram Richter, Ramat Hasharon, IL;

Gershon Golomb, Efrat, IL;

Jonah B. Sacha, Beaverton, OR (US);

Assignees:

BIOREST LTD., Tel Aviv, IL;

OREGON HEALTH & SCIENCE UNIVERSITY, Portland, OR (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/663 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01); A61K 47/24 (2006.01); A61K 9/51 (2006.01);
U.S. Cl.
CPC ...
A61K 31/663 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); A61K 47/24 (2013.01); A61K 9/5153 (2013.01);
Abstract

The present invention relates to use of bisphosphonate formulations for the treatment and management of HIV/AIDS. The method of the invention comprises administering a formulation comprising an effective amount of a bisphosphonate that specifically inhibits the activity and/or decreases the number of monocytes and/or macrophages, thereby reducing or eliminating HIV reservoirs. The invention also provides a method of complementing an HIV antiviral therapy, such as the highly active antiretroviral therapy (HAART), with a bisphosphonate formulation to improve clinical outcome.


Find Patent Forward Citations

Loading…